Pathologic Stage IV Cutaneous Melanoma AJCC v8
Showing 1 - 25 of 29
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Natural Killer Cell Therapy
- Temozolomide
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 28, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Magnetic Resonance Imaging using 7 Tesla MRI
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
- Acute Myeloid Leukemia
- +33 more
- Biospecimen Collection
- Medical Chart Review
-
Kingman, Arizona
- +99 more
Nov 3, 2022
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Ipilimumab
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +19 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 19, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +2 more
- Binimetinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +13 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,
Recruiting
- Advanced Bladder Carcinoma
- +34 more
- Atezolizumab
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Microbiome on Immune Checkpoint Inhibitor Response in Melanoma
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Pathologic Stage IV Cutaneous Melanoma AJCC v8
- Biospecimen Collection
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 31, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
Pharmacogenomics Testing in Directing Optimal Use of Supportive
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +45 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Feb 3, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib Mesylate
- +3 more
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine
Dec 29, 2021
Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States
Recruiting
- Acral Lentiginous Melanoma
- +6 more
- Binimetinib
- +3 more
-
Birmingham, Alabama
- +309 more
Nov 8, 2021